|
|
|
Insider
Information: |
Stahl Neil |
Relationship: |
EVP Research and Devel... |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
50,999 |
|
Indirect Shares
|
10,439 |
|
|
Direct
Value |
$49,823,983 |
|
|
Indirect Value
|
$10,198,485 |
|
|
Total
Shares |
61,438 |
|
|
Total
Value |
$60,022,468 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
5
|
Stock
price went up :
|
0
|
4
|
Stock
price went down : |
0
|
1
|
|
|
|
Gain/Loss Ratio : |
0.0
|
4.0
|
Percentage
Gain/Loss : |
0.0%
|
55.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Regeneron Pharmaceuticals Inc |
REGN |
EVP Research and Devel... |
2024-02-26 |
50,999 |
2024-02-26 |
10,439 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
140 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 6
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
REGN |
Regeneron Pharmaceuticals... |
SVP, PreclinDevel & Biomol Sci |
|
2003-01-13 |
4 |
GD |
$19.65 |
$4,913 |
D/D |
250 |
15,482 |
|
- |
|
REGN |
Regeneron Pharmaceuticals... |
SVP Research and Development S |
|
2014-11-18 |
4 |
GD |
$0.00 |
$0 |
D/D |
250 |
18,584 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
EVP Research and Development |
|
2022-11-08 |
4 |
GD |
$0.00 |
$0 |
D/D |
330 |
52,465 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
EVP Research and Development |
|
2022-02-18 |
4 |
GD |
$0.00 |
$0 |
D/D |
335 |
52,795 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
EVP Research and Development |
|
2023-11-10 |
4 |
GD |
$0.00 |
$0 |
D/D |
400 |
52,700 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
EVP Research and Development |
|
2021-02-25 |
4 |
GD |
$0.00 |
$0 |
D/D |
435 |
24,280 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
EVP Research and Development |
|
2022-12-09 |
4 |
D |
$753.28 |
$351,028 |
D/D |
(466) |
51,999 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
officerTitle |
|
2005-11-18 |
4 |
GD |
$0.00 |
$0 |
D/D |
500 |
4,871 |
|
- |
|
REGN |
Regeneron Pharmaceuticals... |
EVP Research and Development |
|
2023-12-11 |
4 |
D |
$844.09 |
$611,965 |
D/D |
(725) |
52,019 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
SVP Research and Development S |
|
2014-08-07 |
4 |
S |
$340.39 |
$252,304 |
D/D |
(741) |
27,273 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
EVP Research and Development |
|
2020-02-26 |
4 |
GD |
$0.00 |
$0 |
D/D |
750 |
20,979 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
EVP Research and Development |
|
2021-12-11 |
4 |
D |
$664.34 |
$500,248 |
D/D |
(753) |
53,130 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
EVP Research and Development |
|
2023-12-08 |
4 |
D |
$843.79 |
$682,626 |
D/D |
(809) |
51,891 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
EVP Research and Development |
|
2023-12-08 |
4 |
A |
$0.00 |
$0 |
D/D |
853 |
52,744 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
EVP Research and Development |
|
2015-05-28 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,000 |
16,405 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
EVP Research and Development |
|
2024-02-26 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,020 |
50,999 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
EVP Research and Development |
|
2022-12-16 |
4 |
A |
$0.00 |
$0 |
D/D |
1,101 |
53,100 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
EVP Research and Development |
|
2019-05-24 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,300 |
21,150 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
EVP Research and Development |
|
2016-02-19 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,500 |
40,470 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
EVP Research and Development |
|
2020-12-09 |
4 |
A |
$0.00 |
$0 |
D/D |
1,688 |
24,715 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
officerTitle |
|
2006-01-09 |
4 |
AS |
$16.88 |
$30,230 |
D/D |
(1,744) |
3,127 |
|
- |
|
REGN |
Regeneron Pharmaceuticals... |
EVP Research and Development |
|
2015-12-16 |
4 |
OE |
$52.03 |
$99,950 |
D/D |
1,921 |
27,594 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
SVP Research and Development S |
|
2014-08-08 |
4 |
S |
$340.60 |
$715,340 |
D/D |
(2,100) |
25,173 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
SVP, PreclinDevel & Biomol Sci |
|
2004-01-09 |
4 |
AS |
$15.18 |
$32,432 |
D/D |
(2,115) |
15,326 |
|
- |
|
REGN |
Regeneron Pharmaceuticals... |
officerTitle |
|
2003-07-09 |
4 |
AS |
$16.31 |
$34,512 |
D/D |
(2,116) |
10,465 |
|
- |
|
140 Records found
|
|
Page 1 of 6 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|